Colloidal Gold Method News Today

Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, Chi...

Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, Chi...

Beroni Group Limited (NSX:BTG) SARS-CoV-2 Antigen Test Kit Received Export Permit    NSX:BTG), an Australia-based diversified biopharmaceutical enterprise today announced that it has received the notification that its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) is granted authorization for export. As announced in December 2020, Beroni Groups SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) has received the CE certification for distribution to the EU markets. This test kit requi...

Sydney, Australia – Beroni Group an Australia-based diversified biopharmaceutical enterprise today announced that it has received the notification that its SARS-CoV-2 Antigen Test Kit is granted authorization for export. As announced in December 2020, Beroni Group’s SARS-CoV-2 Antigen Test Kit has received the CE certification for distribution to the EU markets. This test kit requires no blood, and only a … Sydney, Australia (ABN Newswire) – Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an A...